DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Van Cutsem E, Rougier P, Köhne CH. et al.
A meta-analysis of the CRYSTAL and OPUS studies combining cetuximab with chemotherapy (CT) as 1st-line treatment for patients (pts) with metastatic colorectal cancer (mCRC): Results according to KRAS and BRAF mutation status.
Eur J Cancer 2009; 7 (Suppl): 345 (Abstract 6077)-
We do not assume any responsibility for the contents of the web pages of other providers.